The purpose of our study was to investigate whether radiomics features
extracted from MRI of BRCA-positive patients with breast masses smaller than 1
cm coupled with machine learning can differentiate benign from malignant lesions using
model-free parameter maps. We included 96 patients with 116 lesions assessed by two readers according to the BI-RADS lexicon. Radiomics features were calculated and included in a machine learning model, along with clinical factors, to
discriminate between malignant and benign lesions. The machine learning model, combining two clinical and three radiomics features, achieved higher diagnostic accuracy (81.5%) compared to morphological assessment alone (53.4%)
This abstract and the presentation materials are available to members only; a login is required.